Press Releases

PRINCETON, N.J., Sept. 24, 2019 /PRNewswire/ -- In today's world, there is no greater commodity than personal health, which is why Jeff B. Smith, former Company Group Chairman of Johnson & Johnson NA, and scientist and former Olympic coach, Sam Bock, are pairing up to launch

Read more...

WOODCLIFF LAKE, N.J., Sept. 24, 2019 /PRNewswire/ -- Eisai today announced the presentation of new data and analyses via one oral proffered paper presentation, four poster discussions and seven poster presentations at the 2019 European Society for Medical Oncology (ESMO) Annual Meeting from September 27 – October

Read more...

WASHINGTON, Sept. 24, 2019 /PRNewswire/ -- Aflac, a committed corporate ally to families facing childhood cancer, and

Read more...

SEATTLE, Sept. 24, 2019 /PRNewswire/ -- A new report by RealSelf, the leading online resource to research aesthetic procedures and connect with doctors,

Read more...

NEW YORK, Sept. 24, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders, today announced that Robb Knie, Chief Executive Officer, will

Read more...

AUSTIN, Texas, Sept. 24, 2019 /PRNewswire/ -- Santé Ventures, a healthcare and life sciences investment firm specializing in early-stage companies developing innovative new medical

Read more...

HARLEYSVILLE, Pa., Sept. 24, 2019 /PRNewswire/ -- Alliance Contract Pharma (ACP) announced today that the Company's new $2 million Li

Read more...

DOVER, Delaware, Sept. 24, 2019 /PRNewswire/ -- CarboFix has announced today that the U.S. Food and Drug Administration (FDA) has cleared its CarboClear® Carbon Fiber Fenestrated Pedicle Screw System used in the treatment of patients with advanced stage spinal tumors.

Read more...

BOTHELL, Wash., Sept. 24, 2019 /PRNewswire/ -- BioLife Solutions

Read more...

SAN DIEGO, Sept. 24, 2019 /PRNewswire/ -- Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients w

Read more...